AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Ultrasonographic Patterns and Pathological Correlation in the Diagnosis of Subcutaneous Nodules

RecruitingNAAges 18 Years - anyAllMahidol University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of this study is to explore the role of ultrasonography (non-invasive imaging device) in the diagnosis of subcutaneous nodules (mass/bumb underneath the skin). Patients who presented with subcutaneous nodules and was indicated for diagnostic skin biopsies were recruited. Prior to skin biopsies (not part of the study's intervention), ultrasonography(intervention) was used to examine the characteristics of the nodules. The ultrasonographic findings are then compared to the pathological results to explore the role of ultrasonography in differentiating each disease or group of diseases that presented with skin nodules.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 years and older who presented with subcutaneous nodules * Indicated for pathological examination for disease diagnosis. * Patients with subcutaneous nodules located in areas where a tissue sample can be taken down to the fat layer. * Patients who agree to participate in the project by signing the consent form. Exclusion Criteria: * Presence of inflammation or other tumors that can mimic panniculitis, such as painful lipomas, cellulitis, and leg interstitial edema. * Patients with diseases that significantly alter the structure of the skin or subcutaneous tissue, such as scleroderma or severe edema. * A history of previous treatments in the area of the subcutaneous mass (e.g., surgery, radiation therapy, or high-dose steroid treatment) that may interfere with ultrasound results. * Patients with lesions on the head or mucous membranes of the body. * Pregnant or breastfeeding patients. * Presence of wounds or open sores in the area to be examined with ultrasound. * A history of coagulopathy (blood clotting disorders). * Patients with metal implants in the area of interest that may interfere with ultrasound imaging. * Participants who refuse or withdraw from the study.
๐Ÿ’Š

What it tests

  • Transcutaneous ultrasound
๐Ÿ“

Where

1 site
Ramathibodi Hospital
Bangkok, Thailand
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy